at www.tipranks.com (Tue, 10-Feb 7:11 AM)
Notable healthcare headlines for the week: Pfizer Novo Nordisk in focus
at seekingalpha.com (Sun, 8-Feb 9:05 AM)
Earnings Scorecard: 22 out of 23 healthcare firms deliver EPS wins this week
at seekingalpha.com (Sat, 7-Feb 11:30 AM)
CVS pharmacies accepting TrumpRx discount cards
at seekingalpha.com (Fri, 6-Feb 4:45 PM)
AMZN’s free cash flow will go negative, GOOGL will not – analyst
at seekingalpha.com (Fri, 6-Feb 1:23 PM)
Pfizer Halts Early-Stage Trial for PF-07258669 in Older Adults: What Investors Should Know
at www.tipranks.com (Fri, 6-Feb 11:31 AM)
Pfizer Completes Mid-Stage Trial of New Obesity Drug Candidate PF-07976016
at www.tipranks.com (Fri, 6-Feb 11:31 AM)
GoodRx becomes pricing source for Pfizer and other drugmakers on TrumpRx
at seekingalpha.com (Fri, 6-Feb 10:47 AM)
Pfizer – Roivant tie-up generates positive mid-stage data for lead asset
at seekingalpha.com (Fri, 6-Feb 9:02 AM)
4 stocks to watch on Friday: PM, PFE, MSTR, HIMS
at seekingalpha.com (Fri, 6-Feb 8:56 AM)
Pfizer wins FDA priority review for Hympavzi label expansion
at seekingalpha.com (Fri, 6-Feb 8:23 AM)
Large-cap stocks with lowest dividend growth grade
at seekingalpha.com (Fri, 6-Feb 7:55 AM)
Market Chameleon (Tue, 3-Feb 7:15 AM)
Pfizer Lowers 2026 Revenue Guidance But Reaffirms Profitability Targets Amid R&D Investment
Market Chameleon (Tue, 16-Dec 7:08 AM)
Market Chameleon (Tue, 9-Dec 7:09 AM)
Pfizer's $7 Billion Metsera Acquisition Strengthens Its Push Into Obesity Treatments
Market Chameleon (Fri, 14-Nov 8:22 AM)
